Pandion Therapeutics Inc

$60.00 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Join the waitlist

About Pandion Therapeutics Inc

Pandion Therapeutics, Inc., formerly Pandion Therapeutics Holdco LLC, is a clinical-stage biopharmaceutical company. The Company is focused on developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. It is developing its Therapeutic Autoimmune reguLatOry protein (TALON) drug design and discovery platform. Its lead product candidate, PT101, a combination of its interleukin-2 (IL-2), mutein effector module with a protein backbone, is designed to selectively expand regulatory Treg cells, without activating proinflammatory cells, such as conventional T cells and natural killer (NK cells).

Stock Analysis

last close $60.05
1-mo return -0.2%
3-mo return 304.4%
avg daily vol. 281.34T
52-week high 62.9
52-week low 10.28
market cap. $1.8B
forward pe -
annual div. -
roe -50%
ltg forecast -
dividend yield -
annual rev. $9M
inst own. -

Join the waitlist for early access and a chance to earn $50 in free stock

Join the waitlist